SEC Charges Ex-Pharmaceutical Company Executive for Allegedly Insider Trading Ahead of Acquisition Announcement
October 01, 2026
October 01, 2026
WASHINGTON, Oct. 1 -- The Securities and Exchange Commission issued the following litigation release:
* * *
Securities and Exchange Commission v. Mukesh Asudani, No. 1:26-cv-_ (S.D.N.Y. filed September 30, 2026)
On September 30, 2026, the SEC filed charges against Mukesh Asudani, a former Senior Vice President of Human Resources at a publicly-traded pharmaceutical company ("Pharma Company A"), for allegedly insider trading ahead of the October 11, . . .
* * *
Securities and Exchange Commission v. Mukesh Asudani, No. 1:26-cv-_ (S.D.N.Y. filed September 30, 2026)
On September 30, 2026, the SEC filed charges against Mukesh Asudani, a former Senior Vice President of Human Resources at a publicly-traded pharmaceutical company ("Pharma Company A"), for allegedly insider trading ahead of the October 11, . . .